The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained

Int J Infect Dis. 2021 Oct:111:196-203. doi: 10.1016/j.ijid.2021.08.060. Epub 2021 Aug 26.

Abstract

Objectives: Streptococcus pneumoniae is the leading bacterial pathogen causing respiratory infections. Since the COVID-19 pandemic emerged, less invasive pneumococcal disease (IPD) was identified by surveillance systems worldwide. Measures to prevent transmission of SARS-CoV-2 also reduce transmission of pneumococci, but this would gradually lead to lower disease rates.

Design: Here, we explore additional factors contributing to the instant drop in pneumococcal disease cases captured in surveillance.

Results: Our observations on referral practices and other impediments to diagnostic testing indicate that residual IPD has likely occurred but remained undetected by conventional hospital-based surveillance.

Conclusions: Depending on the setting, we discuss alternative monitoring strategies that could improve understanding of pneumococcal disease dynamics.

Keywords: COVID-19; IPD; Pandemic; S. pneumoniae; Surveillance.

MeSH terms

  • Adult
  • COVID-19*
  • Humans
  • Incidence
  • Infant
  • Netherlands / epidemiology
  • Pandemics
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Vaccines
  • SARS-CoV-2

Substances

  • Pneumococcal Vaccines